Perivis

Jubilant Ingrevia Limited Q4 FY25 Call date · May 13, 2025 1 · Management Commentary Key Positives Sustained growth in revenue and margins for Specialty Chemicals and Nutrition businesses. Q4 EBITDA margin reached 14.7%; PAT up 153% YoY. Specialty Chemicals segment achieved highest-ever EBITDA (Rs.129 crore) and margin (27%) in 15 quarters. Nutrition & Health … Read more

Tata Steel Limited Q4 FY25 Call date · May 13, 2025 1 · Management Commentary Key Positives Achieved highest ever crude steel production of ~21.7 million tons and deliveries of ~20.9 million tons for FY25. India operations maintained near 100% capacity utilization (ex-Kalinganagar) and delivered strong growth in branded products (Tata Tiscon volumes up 19% … Read more

Tata Motors Limited Q4 FY25 Call date · May 13, 2025 1 · Management Commentary Key Positives Record high revenues and PBT before exceptional items for both Q4 and FY25. Net debt reduced from Rs. 43,000 crores (FY23) to net cash of Rs. 1,000 crores, reflecting strong deleveraging. JLR achieved net cash positive target, highest … Read more

Muthoot Finance Ltd. Q4 FY25 Call date · May 14, 2025 1 · Management Commentary Key Positives Achieved highest ever consolidated loan AUM of Rs.1,22,000 crores as of March 2025, with YoY growth of Rs.33,000 crores (37%). Consolidated PAT at Rs.5,352 crores, up 20% YoY; standalone PAT at Rs.5,200 crores, up 28% YoY. Gold loan … Read more

Blue Jet Healthcare Limited Q4 FY25 Call date · May 14, 2025 1 · Management Commentary Key Positives Record-setting year with highest-ever revenue, EBITDA, and PAT on both quarterly and annual basis. Q4 FY25 revenue from operations at Rs. 3,404 million (up 7% QoQ, 85% YoY); EBITDA at Rs. 1,400 million with 41% margin. FY25 … Read more

Section 1: Quarterly Themes & Tone Changes Q4 FY24 (May 2024) Q1 FY25 (Aug 2024) Q2 FY25 (Nov 2024) Q3 FY25 (Feb 2025) Summary of Tone Evolution:The tone shifted from highly confident and celebratory (Q4 FY24, Q1 FY25) to more balanced and realistic (Q2, Q3 FY25), as management acknowledged execution delays, cash flow pressures, and … Read more

Jyothy Labs Limited Q4 FY25 Call date · May 12, 2025 1 · Management Commentary Key Positives Fabric Care grew 2.1% in Q4 and 5% for FY25, led by strong volume growth, especially in liquid detergents. Ujala IDD Detergent Powder gained Kerala market share to 24.5% (from 23.4% in FY24); Southern India liquids revenue nearly … Read more

Vijaya Diagnostic Centre Limited Q4 FY25 Call date · May 12, 2025 1 · Management Commentary Key Positives Successful launch of 6 new hubs in the last 2 months (2 each in Pune, Bengaluru, and West Bengal). 3 more hubs in West Bengal to commence operations in next 3–4 months; leases finalized for 2 hubs … Read more

Birla Corporation Limited Q4 FY25 Call date · May 12, 2025 1 · Management Commentary Key Positives Q4 saw a 7% QoQ improvement in realizations, driven by higher prices in North and East regions and increased volumes in the West. EBITDA per ton exceeded Rs. 1,000, with no one-offs or incentives distorting operational performance. Mukutban … Read more

R Systems International Limited Q1 FY25 Call date · May 09, 2025 1 · Management Commentary Key Positives Robust pipeline of large deals, with several key wins in Q1 across North America, Europe, and APAC. Year-on-year revenue growth of 6.2% to INR 442.5 crore; adjusted EBITDA up 28.1% YoY to INR 76.8 crore. EBITDA margin … Read more